N-(4-methoxy-5-((4-(1-methyl-1H-pyrrolo[3,2-b]pyridin-3-yl)pyrimidin-2-yl)amino)-2-(4-methylpiperazin-1-yl)phenyl)acrylamide

ID: ALA4475620

PubChem CID: 126667225

Max Phase: Preclinical

Molecular Formula: C27H30N8O2

Molecular Weight: 498.59

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cccnc34)n2)c(OC)cc1N1CCN(C)CC1

Standard InChI:  InChI=1S/C27H30N8O2/c1-5-25(36)30-20-15-21(24(37-4)16-23(20)35-13-11-33(2)12-14-35)32-27-29-10-8-19(31-27)18-17-34(3)22-7-6-9-28-26(18)22/h5-10,15-17H,1,11-14H2,2-4H3,(H,30,36)(H,29,31,32)

Standard InChI Key:  BPAGAPMSJBUTKT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   35.5629  -10.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5618  -11.7360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2698  -12.1450    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.2680  -10.5076    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9766  -10.9129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9814  -11.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7615  -11.9799    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.2388  -11.3148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7537  -10.6554    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.0172  -12.7511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4722  -13.3615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.7287  -14.1366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5297  -14.3024    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.0739  -13.6871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8145  -12.9144    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.7782  -14.0945    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.4863  -13.6865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1916  -14.1002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8991  -13.6929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9002  -12.8748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1878  -12.4658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4832  -12.8755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1856  -11.6486    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.4768  -11.2420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4746  -10.4248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7702  -11.6525    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.1811  -10.0142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1882  -14.9174    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.4789  -15.3231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6077  -12.4658    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.0017   -9.8726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3127  -12.8775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0181  -12.4720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0218  -11.6545    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.3141  -11.2441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6025  -11.6512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.7309  -11.2482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  7 10  1  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  2  0
 18 28  1  0
 28 29  1  0
 20 30  1  0
  9 31  1  0
 30 32  1  0
 30 36  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 34 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475620

    ---

Associated Targets(Human)

NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 498.59Molecular Weight (Monoisotopic): 498.2492AlogP: 3.66#Rotatable Bonds: 7
Polar Surface Area: 100.44Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.60CX Basic pKa: 7.56CX LogP: 3.48CX LogD: 3.09
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.37Np Likeness Score: -1.13

References

1. Zhou P, Chen G, Gao M, Wu J..  (2018)  Design, synthesis and evaluation of the osimertinib analogue (C-005) as potent EGFR inhibitor against NSCLC.,  26  (23-24): [PMID:30442506] [10.1016/j.bmc.2018.10.018]

Source